Literature DB >> 11144087

Effects of inhaled nitric oxide in a canine living-donor lobar lung transplant model.

K Ueda1, H Date, T Fujita, T Oto, I Nagahiro, M Aoe, A Andou, N Shimizu.   

Abstract

OBJECTIVE: In living-donor lobar lung transplantation, early severe graft dysfunction can occur if the size or amount of transplanted lung tissue is insufficient. The purpose of this study was to evaluate the effects of inhaled nitric oxide on early pulmonary function in a canine bilateral living-donor lobar lung transplant model.
METHODS: Sixteen pairs of mongrel dogs with a donor/recipient weight ratio less than 1.2 were used. The donor lung bloc was extirpated after heparinization. Right middle, lower and cardiac lobes were implanted as a right lung of the recipient and left lower lobe was implanted as a left lung without cardiopulmonary bypass. In Group 1 (n = 9), nitric oxide gas was administered continuously at a concentration of 40 parts per million prior to reperfusion of the right lung throughout the 6-hour assessment period after transplantation. In Group 2 (n = 7), nitrogen gas was administered in the same manner as nitric oxide, for control.
RESULTS: At the end of assessment, the survival rate was 89% (8/9) in Group 1 and 57% (4/7) in Group 2. The arterial oxygen tension in Group 1 was significantly higher than that in Group 2. The pulmonary arterial pressure and pulmonary vascular resistance index were significantly lower in Group 1 than in Group 2. The aortic pressure and cardiac index did not differ significantly between the two groups. The wet-to-dry weight ratio and myeloperoxidase activity were significantly lower in Group 1 than in Group 2.
CONCLUSIONS: These data suggested that inhaled nitric oxide improved early pulmonary function in living-donor lobar lung transplantation by vasodilatating the pulmonary vasculature and inhibiting neutrophil activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11144087     DOI: 10.1007/BF03218234

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  17 in total

1.  Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension.

Authors:  J Pepke-Zaba; T W Higenbottam; A T Dinh-Xuan; D Stone; J Wallwork
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

2.  Experience with living-donor lobar transplantation for indications other than cystic fibrosis.

Authors:  V A Starnes; M L Barr; F A Schenkel; M V Horn; R G Cohen; J A Hagen; W J Wells
Journal:  J Thorac Cardiovasc Surg       Date:  1997-12       Impact factor: 5.209

3.  Living-donor lobar lung transplantation experience: intermediate results.

Authors:  V A Starnes; M L Barr; R G Cohen; J A Hagen; W J Wells; M V Horn; F A Schenkel
Journal:  J Thorac Cardiovasc Surg       Date:  1996-11       Impact factor: 5.209

4.  Prevention of reperfusion injury by inhaled nitric oxide in lungs harvested from non-heart-beating donors. Paris-Sud University Lung Transplantation Group.

Authors:  S Murakami; E A Bacha; P Hervé; H Détruit; A R Chapelier; P G Dartevelle; G M Mazmanian
Journal:  Ann Thorac Surg       Date:  1996-12       Impact factor: 4.330

5.  Size disparity in pediatric lung transplantation.

Authors:  C W Lillehei; R C Shamberger; J E Mayer; R P Burke; B V Koka; J Arnold; D L Wessel; M Lanzberg; R Palazzo
Journal:  J Pediatr Surg       Date:  1994-08       Impact factor: 2.545

6.  Inhaled nitric oxide reduces human lung allograft dysfunction.

Authors:  H Date; A N Triantafillou; E P Trulock; M S Pohl; J D Cooper; G A Patterson
Journal:  J Thorac Cardiovasc Surg       Date:  1996-05       Impact factor: 5.209

7.  Inhaled nitric oxide for the adult respiratory distress syndrome.

Authors:  R Rossaint; K J Falke; F López; K Slama; U Pison; W M Zapol
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

8.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

Authors:  J E Krawisz; P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

9.  Effects of inhaled nitric oxide in canine lung transplantation from non-heart-beating donor.

Authors:  S Takashima; H Date; M Aoe; M Yamashita; A Andou; N Shimizu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-08

10.  Lobar transplantation. Indications, technique, and outcome.

Authors:  V A Starnes; M L Barr; R G Cohen
Journal:  J Thorac Cardiovasc Surg       Date:  1994-09       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.